Company Gencurix Inc.

Equities

A229000

KR7229000005

Medical Equipment, Supplies & Distribution

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Sales per region

Sector Diagnostic & Testing Substances

End-of-day quote Korea S.E. Other stock markets 18:00:00 2024-05-19 EDT			5-day change	1st Jan Change
3,075 ^KRW	-2.84%		-2.84%	-50.56%

04-15	J&L Agent Co., Ltd. and other buyer completed the acquisition of 4.97% stake in NGeneBio Co., Ltd. from Gencurix Inc. for KRW 3 billion.	CI
04-03	J&L Agent Co., Ltd. and other buyer agreed to acquire 4.97% stake in NGeneBio Co., Ltd. from Gencurix Inc. for KRW 3.2 billion.	CI

Gencurix Inc. is a Korea-based company mainly engaged in the sale of medical equipments. In addition, the Company is involved in the manufacturing and sale of breast cancer test (BCT) kits, Korean genetic polymorphism diagnostic kits, lung cancer and colorectal cancer diagnostic kits. The BCT kits are used for analyzing the expression level of the cancer-related gene. The products are sold under the name of GenesWell.

KRW in Million	2022	Weight	2023	Weight	Delta
Cancer Diagnosis (Prognostic Diagnosis + Companion Diagnosis) 92.4 %	-	-	2,403	92.4 %	-
Others 7.6 %	4	0.1 %	197	7.6 %	+5,524.80%

KRW in Million	2022	Weight	2023	Weight	Delta
South Korea 95.8 %	2,312	90.3 %	2,491	95.8 %	+7.76%
Overseas 4.2 %	248	9.7 %	109	4.2 %	-55.94%

Managers	Title	Age	Since
Sang-Rae Cho CEO	Chief Executive Officer	51	-
Jong-Heun Lee CTO	Chief Tech/Sci/R&D Officer	52	-
Young-Ho Moon CTO	Chief Tech/Sci/R&D Officer	62	14-12-31
Wan-Seok Cho AUD	Comptroller/Controller/Auditor	54	-

Members of the board	Title	Age	Since
Myung-Hwan Kim BRD	Director/Board Member	54	-
Sang-Rae Cho CEO	Chief Executive Officer	51	-
Young-Ho Moon CTO	Chief Tech/Sci/R&D Officer	62	14-12-31
Su-Jin Park BRD	Director/Board Member	46	16-12-27

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	14,444,005	11,956,991 ( 82.78 %)	0	82.78 %
Stock B	0	47,511	0	0

Name	Equities	%	Valuation
Sang-Rae Cho 10.56 %	1,522,911	10.56 %	3 M ₩
Kumsung Baekjo Construction Co., Ltd. 5.019 %	723,707	5.019 %	2 M ₩
Samsung Asset Management Co., Ltd. 3.616 %	521,375	3.616 %	1 M ₩
Daeseung Global Co. Ltd. 0.7843 %	113,095	0.7843 %	257 759 ₩
KumsungBaekjoe Co. Ltd. 0.7490 %	108,006	0.7490 %	246 161 ₩
Young-Ho Moon 0.1717 %	24,753	0.1717 %	56 416 ₩
Su-kyung Kim 0.0428 %	6,173	0.0428 %	14 069 ₩

Name	Equities	%	Valuation
NGENEBIO CO., LTD. 11.64%	1,500,000	11.64%	4,596,270 $

Gencurix, Inc.

#402, Hanhwa Bizmetro I 242 Digital-ro

08394, Seoul

http://gencurix.com

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Diagnostic & Testing Substances

	1st Jan change	Capi.
GENCURIX INC.	-50.56%	33.78M
BIOMÉRIEUX	-5.27%	12.32B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-3.86%	8.07B
LANTHEUS HOLDINGS, INC.	+33.66%	5.52B
AUTOBIO DIAGNOSTICS CO., LTD.	-7.35%	4.21B
10X GENOMICS, INC.	-55.63%	2.99B
ANDON HEALTH CO., LTD.	+13.62%	2.73B
VITROLIFE AB	-3.65%	2.43B
MYRIAD GENETICS, INC.	+30.67%	2.29B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-4.31%	1.89B

Diagnostic & Testing Substances